|
1.
|
Benezra R, Davis RL, Lockshon D, Turner DL
and Weintraub H: The protein id: a negative regulator of
helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Alani RM, Hasskarl J, Grace M, Hernandez
MC, Israel MA and Munger K: Immortalization of primary human
keratinocytes by the helix-loop-helix protein, id-1. Proc Natl Acad
Sci USA. 96:9637–9641. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Ohtani N, Zebedee Z, Huot TJ, Stinson JA,
Sugimoto M, Ohashi Y, Sharrocks AD, Peters G and Hara E: Opposing
effects of ets and id proteins on p16ink4a expression during
cellular senescence. Nature. 409:1067–1070. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Ling MT, Wang X, Ouyang XS, Lee TK, Fan
TY, Xu K, Tsao SW and Wong YC: Activation of MAPK signaling pathway
is essential for id-1 induced serum independent prostate cancer
cell growth. Oncogene. 21:8498–8505. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Swarbrick A, Akerfeldt MC, Lee CS, Sergio
CM, Caldon CE, Hunter LJ, Sutherland RL and Musgrove EA: Regulation
of cyclin expression and cell cycle progression in breast
epithelial cells by the helix-loop-helix protein id1. Oncogene.
24:381–389. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Ling MT, Wang X, Ouyang XS, Xu K, Tsao SW
and Wong YC: Id-1 expression promotes cell survival through
activation of nf-kappab signalling pathway in prostate cancer
cells. Oncogene. 22:4498–4508. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Desprez PY, Lin CQ, Thomasset N, Sympson
CJ, Bissell MJ and Campisi J: A novel pathway for mammary
epithelial cell invasion induced by the helix-loop-helix protein
id-1. Mol Cell Biol. 18:4577–4588. 1998.PubMed/NCBI
|
|
8.
|
Lin CQ, Singh J, Murata K, Itahana Y,
Parrinello S, Liang SH, Gillett CE, Campisi J and Desprez PY: A
role for id-1 in the aggressive phenotype and steroid hormone
response of human breast cancer cells. Cancer Res. 60:1332–1340.
2000.PubMed/NCBI
|
|
9.
|
Fong S, Itahana Y, Sumida T, Singh J,
Coppe JP, Liu Y, Richards PC, Bennington JL, Lee NM, Debs RJ and
Desprez PY: Id-1 as a molecular target in therapy for breast cancer
cell invasion and metastasis. Proc Natl Acad Sci USA.
100:13543–13548. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu
W, Giri DD, Viale A, Olshen AB, Gerald WL and Massague J: Genes
that mediate breast cancer metastasis to lung. Nature. 436:518–524.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Jang TJ, Jung KH and Choi EA: Id-1 gene
downregulation by sulindac sulfide and its upregulation during
tumor development in gastric cancer. Int J Cancer. 118:1356–1363.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Coppe JP, Itahana Y, Moore DH, Bennington
JL and Desprez PY: Id-1 and id-2 proteins as molecular markers for
human prostate cancer progression. Clin Cancer Res. 10:2044–2051.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Kebebew E, Peng M, Treseler PA, Clark OH,
Duh QY, Ginzinger D and Miner R: Id1 gene expression is
up-regulated in hyperplastic and neoplastic thyroid tissue and
regulates growth and differentiation in thyroid cancer cells. J
Clin Endocrinol Metab. 89:6105–6111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lee KT, Lee YW, Lee JK, Choi SH, Rhee JC,
Paik SS and Kong G: Overexpression of id-1 is significantly
associated with tumour angiogenesis in human pancreas cancers. Br J
Cancer. 90:1198–1203. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Yuen HF, Chan YP, Chan KK, Chu YY, Wong
ML, Law SY, Srivastava G, Wong YC, Wang X and Chan KW: Id-1 and
id-2 are markers for metastasis and prognosis in oesophageal
squamous cell carcinoma. Br J Cancer. 97:1409–1415. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Ouyang XS, Wang X, Lee DT, Tsao SW and
Wong YC: Overexpression of id-1 in prostate cancer. J Urol.
167:2598–2602. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Jang KS, Han HX, Paik SS, Brown PH and
Kong G: Id-1 over-expression in invasive ductal carcinoma cells is
significantly associated with intratumoral microvessel density in
er-negative/node-positive breast cancer. Cancer Lett. 244:203–210.
2006. View Article : Google Scholar
|
|
18.
|
Schindl M, Schoppmann SF, Strobel T,
Heinzl H, Leisser C, Horvat R and Birner P: Level of id-1 protein
expression correlates with poor differentiation, enhanced malignant
potential and more aggressive clinical behavior of epithelial
ovarian tumors. Clin Cancer Res. 9:779–785. 2003.
|
|
19.
|
Maw MK, Fujimoto J and Tamaya T:
Expression of the inhibitor of DNA-binding (id)-1 protein as an
angiogenic mediator in tumour advancement of uterine cervical
cancers. Br J Cancer. 99:1557–1563. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Takai N, Miyazaki T, Fujisawa K, Nasu K
and Miyakawa I: Id1 expression is associated with histological
grade and invasive behavior in endometrial carcinoma. Cancer Lett.
165:185–193. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
International Federation of Obstetrics and
Gynecology (FIGO) News: Int J Gynecol Obstet, FIGO News.
28:189–193. 1989. View Article : Google Scholar
|
|
22.
|
McCarty KS Jr, Miller LS, Cox EB, Konrath
J and McCarty KS Sr: Estrogen receptor analyses. Correlation of
biochemical and immunohistochemical methods using monoclonal
antireceptor antibodies. Arch Pathol Lab Med. 109:716–721.
1985.
|
|
23.
|
Giatromanolaki A, Sivridis E, Brekken R,
Thorpe PE, Anastasiadis P, Gatter KC, Harris AL and Koukourakis MI:
The angiogenic ‘vascular endothelial growth factor/flk-1(kdr)
receptor’ pathway in patients with endometrial carcinoma:
prognostic and therapeutic implications. Cancer. 92:2569–2577.
2001.
|
|
24.
|
Maeda K, Chung YS, Ogawa Y, Takatsuka S,
Kang SM, Ogawa M, Sawada T, Onoda N, Kato Y and Sowa M: Thymidine
phosphorylase/platelet-derived endothelial cell growth factor
expression associated with hepatic metastasis in gastric carcinoma.
Br J Cancer. 73:884–888. 1996. View Article : Google Scholar
|
|
25.
|
Chomczynski P and Sacchi N: Single-step
method of RNA isolation by acid guanidinium
thiocyanate-phenol-chloroform extraction. Anal Biochem.
162:156–159. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Maruyama H, Kleeff J, Wildi S, Friess H,
Buchler MW, Israel MA and Korc M: Id-1 and id-2 are overexpressed
in pancreatic cancer and in dysplastic lesions in chronic
pancreatitis. Am J Pathol. 155:815–822. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Lyden D, Young AZ, Zagzag D, Yan W, Gerald
W, O'Reilly R, Bader BL, Hynes RO, Zhuang Y, Manova K and Benezra
R: Id1 and id3 are required for neurogenesis, angiogenesis and
vascularization of tumour xenografts. Nature. 401:670–677. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Volpert OV, Pili R, Sikder HA, Nelius T,
Zaichuk T, Morris C, Shiflett CB, Devlin MK, Conant K and Alani RM:
Id1 regulates angiogenesis through transcriptional repression of
thrombospondin-1. Cancer Cell. 2:473–483. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Ling MT, Lau TC, Zhou C, Chua CW, Kwok WK,
Wang Q, Wang X and Wong YC: Overexpression of id-1 in prostate
cancer cells promotes angiogenesis through the activation of
vascular endothelial growth factor (VEGF). Carcinogenesis.
26:1668–1676. 2005. View Article : Google Scholar : PubMed/NCBI
|
